These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 29601115)

  • 1. Long-Term Beta-Blocker Therapy after Myocardial Infarction in the Reperfusion Era: A Systematic Review.
    Hong J; Barry AR
    Pharmacotherapy; 2018 May; 38(5):546-554. PubMed ID: 29601115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials.
    Bangalore S; Makani H; Radford M; Thakur K; Toklu B; Katz SD; DiNicolantonio JJ; Devereaux PJ; Alexander KP; Wetterslev J; Messerli FH
    Am J Med; 2014 Oct; 127(10):939-53. PubMed ID: 24927909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial.
    Kristensen AMD; Bovin A; Zwisler AD; Cerquira C; Torp-Pedersen C; Bøtker HE; Gustafsson I; Veien KT; Thomsen KK; Olsen MH; Larsen ML; Nielsen OW; Hildebrandt P; Foghmar S; Jensen SE; Lange T; Sehested T; Jernberg T; Atar D; Ibanez B; Prescott E
    Trials; 2020 May; 21(1):415. PubMed ID: 32446298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study.
    Munkhaugen J; Ruddox V; Halvorsen S; Dammen T; Fagerland MW; Hernæs KH; Vethe NT; Prescott E; Jensen SE; Rødevand O; Jortveit J; Bendz B; Schirmer H; Køber L; Bøtker HE; Larsen AI; Vikenes K; Steigen T; Wiseth R; Pedersen T; Edvardsen T; Otterstad JE; Atar D
    Am Heart J; 2019 Feb; 208():37-46. PubMed ID: 30530121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Beta-Blocker Therapy After Myocardial Infarction Without Heart Failure in the Reperfusion Era-Systemic Review and Meta-analysis.
    Kim Y; Byun S; Kim HY; Kim DB
    J Cardiovasc Pharmacol; 2022 May; 79(5):650-654. PubMed ID: 35058412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reappraisal of beta-blocker therapy in the acute and chronic post-myocardial infarction period.
    Borrello F; Beahan M; Klein L; Gheorghiade M
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S13-24. PubMed ID: 14564230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-Blocker Use after Discharge in Patients with Acute Myocardial Infarction in the Contemporary Reperfusion Era.
    Hu M; Hu S; Gao X; Yang Y
    Medicina (Kaunas); 2022 Aug; 58(9):. PubMed ID: 36143854
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta-adrenergic blockers in patients with acute myocardial infarction.
    Furberg CD; Byington RP
    Cardiovasc Clin; 1989; 20(1):235-48. PubMed ID: 2565768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blocker underuse in secondary prevention of myocardial infarction.
    Everly MJ; Heaton PC; Cluxton RJ
    Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative beta-blockers for preventing surgery-related mortality and morbidity.
    Blessberger H; Kammler J; Domanovits H; Schlager O; Wildner B; Azar D; Schillinger M; Wiesbauer F; Steinwender C
    Cochrane Database Syst Rev; 2014 Sep; (9):CD004476. PubMed ID: 25233038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are beta-blockers effective in patients who develop heart failure soon after myocardial infarction? A meta-regression analysis of randomised trials.
    Houghton T; Freemantle N; Cleland JG
    Eur J Heart Fail; 2000 Sep; 2(3):333-40. PubMed ID: 10938496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery.
    Zhang H; Yuan X; Zhang H; Chen S; Zhao Y; Hua K; Rao C; Wang W; Sun H; Hu S; Zheng Z
    Circulation; 2015 Jun; 131(25):2194-201. PubMed ID: 25908770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of oral beta-blocker therapy on mortality after primary percutaneous coronary intervention for Killip class 1 myocardial infarction.
    Hioki H; Motoki H; Izawa A; Kashima Y; Miura T; Ebisawa S; Tomita T; Miyashita Y; Koyama J; Ikeda U
    Heart Vessels; 2016 May; 31(5):687-93. PubMed ID: 25863805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefit of β-blocker treatment for patients with acute myocardial infarction and preserved systolic function after percutaneous coronary intervention.
    Choo EH; Chang K; Ahn Y; Jeon DS; Lee JM; Kim DB; Her SH; Park CS; Kim HY; Yoo KD; Jeong MH; Seung KB
    Heart; 2014 Mar; 100(6):492-9. PubMed ID: 24395980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive adrenergic blockade post myocardial infarction left ventricular dysfunction.
    Fonarow GC
    Cardiol Clin; 2008 Feb; 26(1):79-89, vii. PubMed ID: 18312908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit of Vasodilating β-Blockers in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention: Nationwide Multicenter Cohort Study.
    Chung J; Han JK; Kim YJ; Kim CJ; Ahn Y; Chan Cho M; Chae SC; Chae IH; Chae JK; Seong IW; Yang HM; Park KW; Kang HJ; Koo BK; Jeong MH; Kim HS;
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do Patients need Lifelong β-Blockers after an Uncomplicated Myocardial Infarction?
    Zeitouni M; Kerneis M; Lattuca B; Guedeney P; Cayla G; Collet JP; Montalescot G; Silvain J
    Am J Cardiovasc Drugs; 2019 Oct; 19(5):431-438. PubMed ID: 30828768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period.
    Hjalmarson A
    Am J Cardiol; 1997 Nov; 80(9B):35J-39J. PubMed ID: 9375948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Events After Discontinuation of β-Blockers in Patients Without Heart Failure Optimally Treated After Acute Myocardial Infarction: A Cohort Study on the French Healthcare Databases.
    Neumann A; Maura G; Weill A; Alla F; Danchin N
    Circ Cardiovasc Qual Outcomes; 2018 Apr; 11(4):e004356. PubMed ID: 29653999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blocker use in ST-segment elevation myocardial infarction in the reperfusion era (GRACE).
    Park KL; Goldberg RJ; Anderson FA; López-Sendón J; Montalescot G; Brieger D; Eagle KA; Wyman A; Gore JM;
    Am J Med; 2014 Jun; 127(6):503-11. PubMed ID: 24561113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.